News > RMMS Defeats Motion for Preliminary Injunction Involving Generic Clobetasol Propionate Foam Products

RMMS Defeats Motion for Preliminary Injunction Involving Generic Clobetasol Propionate Foam Products

03/19/2008

On March 19, 2008, RMMS successfully defeated Plaintiffs Connetics Corporation and Connetics Australia Pty. Ltd.'s motion for preliminary injunction against the firm's client, Perrigo Israel Pharmaceuticals Ltd. (formerly Agis Industries (1983) Ltd.). After briefing and hearing argument on Plaintiffs' motion to enjoin Perrigo from launching its FDA-approved generic version of Olux®, the U.S. District Court for the District of New Jersey denied Plaintiffs' motion from the bench. As a result of this ruling, Perrigo is now on the market with its generic clobetasol propionate foam product.